Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

About the Company

医铭康达(北京)生物医药有限公司于2022 年8 月成立,由清华大学讲席教授、昌平实验室教授傅阳心教授转化、由产业资深专家傅道田博士共同创立。主要从事新一代基于免疫治疗的生物创新药的研发,旨在突破肿瘤、自免和治疗性疫苗的免疫治疗现有瓶颈。医铭康达以源头创新为核心、以免疫治疗为基础、以临床价值为导向,充分结合前沿科学创新和产业转化的能力,促进产学研充分合作并实现创新的高效转化,来打造新一代免疫驱动的创新生物药研发公司。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

医铭康达 Recruitment Overview / Current Status (9 open positions)

Manage
Note: How fast is hiring at 医铭康达(北京)生物医药有限公司 growing? . A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

医铭康达 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

医铭康达 Related Industry Tags

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 401.9608万(元)
Legal Representative: 傅道田(FU,DAOTIAN)
Date Established:
Credit Code: 91110114MABWEYFG1A
Registered Address: 北京市昌平区生命科学园生命园路9号院1号楼402室

People who follow 医铭康达 also follow

医铭康达 Competitors (Similar Companies)

医药 抗体 生物医药 抗肿瘤药
药物研发 临床研究 临床医学 研发
基因合成 生物科技/生物工程 试剂 分子生物学
研究院/研究所 农业 分子生物学 蛋白质组学
“A biopharmaceutical enterprise integrating scientific research and dev”
“Life Sciences and Integrated Medicine”
分子生物学试剂 酸分离 分离纯化 分子生物学实验
“Focused on developing high-throughput sequencing experimental technolo”
医药 制药/药业 药物研发 医药工业
医药 新药研发 CRO 医药CRO
生物科技/生物工程 生命科学 制药/药业 试剂
临床诊断 诊断试剂 POCT 临床医学
分子诊断 医学诊断 医学检验 临床检验
“专注于新一代DNA技术及其在合成生物学领域的应用”
“肿瘤药物研发企业”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates